Charles River Laboratories International, Inc.’s CRL share price has surged by 15.85%, which has investors questioning if ...

Charles River Laboratories International ... The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services ...

For those unfamiliar with Charles River, the company breeds and sells rodents, rats, and mice for research purposes and serves some of the largest pharmaceutical companies in the world.

Charles River provides over 150 different strains, primarily focusing on rats and mice, which are the most widely used rodent models. Clients can also specify the sub-strain, animal ...

Charles River's stock climbed to $133.36, though it has fallen approximately 37% year-to-date as the company and other contract drugmakers face sluggish demand among smaller biotech companies ...

BEVERLY HILLS, May 7 (Reuters) - Pharmaceutical company Charles River Laboratories (CRL.N), opens new tab has reached a settlement with activist investor Elliott Investment Management to add four ...

WILMINGTON, Mass., May 07, 2025--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced that four new directors will join its Board of Directors and that four ...

BEVERLY HILLS (Reuters) -Pharmaceutical company Charles River Laboratories has reached a settlement with activist investor Elliott Investment Management to add four new directors to its board and ...

Charles River Raises 2025 Profit Forecast, Reaches Deal With Activist Investor By Siddhi Mahatole and Sriparna Roy (Reuters) -Charles River Laboratories shares jumped 15% on Wednesday after the ...